GlaxoSmithKline Boostrix
This settlement closed on June 8, 2026. It resolved a class action against GlaxoSmithKline (GSK) alleging that its 'Big Bad Cough' advertising campaign misled New York residents into getting the Boostrix vaccine primarily to protect others. Eligible claimants who filed in time received either $50 with vaccination proof or $10 without it.
$50 with qualifying vaccination proof; $10 without proof
Claimants who submitted qualifying proof of their Boostrix vaccination received $50. Those who filed without proof received $10.
Official site: bigbadcoughsettlement.com
Who may qualify
New York residents who saw GSK's 'Big Bad Cough' advertising campaign between 2015 and 2020 and got the Boostrix vaccine between May 20, 2016 and May 20, 2020 believing it would protect someone else.
Official eligibility wording
New York residents who viewed the 'Big Bad Cough' advertising campaign between 2015 and 2020 and received a Boostrix vaccine between May 20, 2016 and May 20, 2020 to protect someone else.
This summary is based on available official settlement sources. The settlement administrator determines eligibility and payment approval.
New to the terms? Plain-English: claim deadline, proof of purchase, administrator, pro rata.
Important dates
- Claim deadline
- June 8, 2026 (closed)
- Exclusion deadline
- May 11, 2026 (passed)
- Objection deadline
- May 11, 2026 (passed)
Proof requirements
Proof requirement is currently marked as Optional.
Review the official claim form before submitting any information.
What you need
Claimants had to submit a claim form and could optionally provide proof of their Boostrix vaccination during the class period; filing with proof qualified for a higher payment.
How do I file a claim for this settlement?
This record no longer has an open public claim form — confirm the current status and any next steps on the official source.
- Confirm you are within the eligible group described in the official notice — the settlement administrator determines eligibility.
- Gather any documents the official form asks for — this settlement marks proof as Optional.
- Open the official claim form or settlement website run by Angeion Group.
- Submit accurate information through the official settlement administrator or government source before June 8, 2026.
- Save your confirmation number if one is provided, then watch the payment status for distribution updates.
New to settlement claims? How to file safely →
Worried it might be fake? Run the 60-second legitimacy check →
How we verified this record
- Claim deadline the official settlement website · Jun 17, 2026
- Payout details the official settlement website · Jun 17, 2026
- Eligibility the official settlement website · Jun 17, 2026
- Proof requirement the official settlement website · Jun 17, 2026
- Administrator the official settlement website · Jun 17, 2026
- Official claim link the official settlement website · Jun 17, 2026
- Court case queued for re-check
- Payment status queued for re-check
Every published record clears our source-verification bar; remaining fields are checked one by one on our weekly re-verification pass.
Checked fields are matched against a named official source and re-checked on a schedule. We show the authority and the date, never our internal evidence link.
-
Claim deadline
June 8, 2026
Verified Jun 17, 2026 · against the official settlement website
-
Eligibility summary
New York residents who viewed the 'Big Bad Cough' advertising campaign between 2015 and 2020 and received a Boostrix vaccine between May 20, 2016 and May 20, 2020 to protect someone else.
Verified Jun 17, 2026 · against the official settlement website
-
Proof requirement
Optional
Verified Jun 17, 2026 · against the official settlement website
-
Estimated payout
$50 with qualifying vaccination proof; $10 without proof
Verified Jun 17, 2026 · against the official settlement website
-
Administrator
Angeion Group
Verified Jun 17, 2026 · against the official settlement website
-
Court
U.S. District Court for the Eastern District of New York
Verified Jun 17, 2026 · against the official settlement website
Show all 6 more verified fields
-
Official claim URL
bigbadcoughsettlement.com
Verified Jun 17, 2026 · against the official settlement website
-
Objection deadline
May 11, 2026
Verified Jun 17, 2026 · against the official settlement website
-
Opt-out deadline
May 11, 2026
Verified Jun 17, 2026 · against the official settlement website
-
Class period start
May 20, 2016
Verified Jun 17, 2026 · against the official settlement website
-
Class period end
May 20, 2020
Verified Jun 17, 2026 · against the official settlement website
-
Case name
DeCostanzo v. GlaxoSmithKline
Verified Jun 17, 2026 · against the official settlement website
Common questions
Is the GlaxoSmithKline Boostrix settlement legitimate?
Yes — the GlaxoSmithKline Boostrix settlement is a real claims process that SettleSignal tracks from its official source. It is administered by Angeion Group. File only through the official settlement website (bigbadcoughsettlement.com); a genuine settlement administrator never charges a fee to file. SettleSignal last checked this record against the official source on June 17, 2026. Always confirm the current details on the official site before filing.
Who may qualify for this settlement?
New York residents who viewed the 'Big Bad Cough' advertising campaign between 2015 and 2020 and received a Boostrix vaccine between May 20, 2016 and May 20, 2020 to protect someone else.
What is the claim deadline?
The claim deadline is June 8, 2026. Confirm the current deadline on the official settlement source before filing.
Do I need proof to claim?
Proof requirement: Optional. The settlement administrator determines what documentation, if any, is required.
What is the current payment status?
Current payment status: Unknown. Payments are issued by the administrator after the court process concludes.
When will GlaxoSmithKline Boostrix pay out?
Current payment status: Unknown. Class-action payouts typically begin only after final approval and any appeals. See our payout timeline guide.
Where is the official GlaxoSmithKline Boostrix claim form?
The official claim form is hosted by the settlement administrator, Angeion Group. Use the 'Open official claim form' button on this page — never pay a fee to file.
Can I still file a claim?
No. The claim deadline was June 8, 2026, and claims are now closed. New submissions are no longer accepted.
What was the GlaxoSmithKline Boostrix settlement about?
The lawsuit, DeCostanzo v. GlaxoSmithKline, alleged that GSK's 'Big Bad Cough' ad campaign misled New York consumers into getting the Boostrix (Tdap) vaccine under the impression it would shield other people — such as newborns — from whooping cough.
Who qualified for this settlement?
People who lived in New York and both viewed the 'Big Bad Cough' campaign between 2015 and 2020 AND received a Boostrix vaccination in New York between May 20, 2016 and May 20, 2020 with the intent to protect someone else.
How much did claimants receive?
Eligible claimants received $50 if they submitted qualifying vaccination proof, or $10 if they filed without proof.
Who administered this settlement?
Angeion Group served as the settlement administrator. The case was overseen by the U.S. District Court for the Eastern District of New York, with a fairness hearing scheduled for July 2, 2026.
Where to act
When you are ready, you open the official claim form yourself. SettleSignal does not file claims or determine eligibility.
The claim deadline (Jun 08, 2026) has passed — this settlement is closed to new claims. Listed for reference.
Listed on the official settlement website (Angeion Group).
Disclaimer
This service summarizes publicly available settlement information and links to official settlement sources. We are not a law firm, do not provide legal advice, do not submit claims on your behalf, and do not determine eligibility or payout approval. Only file a claim if the information you provide is accurate.
Change log
- June 17, 2026 — Settlement published after verification.
- June 17, 2026 — Verified field details updated from an official source.